Bernal-Morales Carolina, Alé-Chilet Aníbal, Martín-Pinardel Ruben, Barraso Marina, Hernández Teresa, Oliva Cristian, Vinagre Irene, Ortega Emilio, Figueras-Roca Marc, Sala-Puigdollers Anna, Gimenez Marga, Esmatjes Enric, Adán Alfredo, Zarranz-Ventura Javier
Institut Clínic d'Oftalmologia (ICOF), Hospital Clínic, 08028 Barcelona, Spain.
August Pi i Sunyer Biomedical Research Institute (IDIBAPS), 08036 Barcelona, Spain.
Diagnostics (Basel). 2021 Aug 25;11(9):1537. doi: 10.3390/diagnostics11091537.
The purpose of this study was to evaluate specifically the relationship between glycated haemoglobin (HbA1c) levels and retinal optical coherence tomography (OCT) and OCT angiography (OCTA) parameters in type 1 Diabetes Mellitus (DM). A total of 478 type 1 DM patients and 115 controls were included in a prospective OCTA trial (ClinicalTrials.gov NCT03422965). Subgroup analysis was performed for controls, no diabetic retinopathy (DM-no DR) and DR patients (DM-DR), and HbA1c levels. OCT and OCTA measurements were compared with HbA1c levels (current and previous 5 years). DM-no DR patients with HbA1c levels >7.5% showed lower VD than DM-DR and controls (20.16 vs. 20.22 vs. 20.71, < 0.05), and showed a significant correlation between HbA1c levels and FAZc ( = 0.04), after adjusting for age, gender, signal strength index, axial length, and DM disease duration. DM-DR patients with HbA1c > 7.5% presented greater CRT than DM-no DR and controls (270.8 vs. 260 vs. 251.1, < 0.05) and showed a significant correlation between HbA1c and CRT ( = 0.03). In conclusion, greater levels of HbA1c are associated with OCTA changes in DM-no DR patients, and with structural OCT changes in DM-DR patients. The combination of OCTA and OCT measurements and HbA1c levels may be helpful to identify patients at risk of progression to greater stages of the diabetic microvascular disease.
本研究的目的是具体评估1型糖尿病(DM)患者糖化血红蛋白(HbA1c)水平与视网膜光学相干断层扫描(OCT)及OCT血管造影(OCTA)参数之间的关系。一项前瞻性OCTA试验(ClinicalTrials.gov NCT03422965)纳入了478例1型DM患者和115例对照。对对照组、无糖尿病视网膜病变(DM-no DR)患者和糖尿病视网膜病变(DM-DR)患者以及HbA1c水平进行亚组分析。将OCT和OCTA测量结果与HbA1c水平(当前及过去5年)进行比较。HbA1c水平>7.5%的DM-no DR患者的视盘周围血管密度(VD)低于DM-DR患者和对照组(分别为20.16、20.22和20.71,<0.05),在调整年龄、性别、信号强度指数、眼轴长度和DM病程后,HbA1c水平与黄斑无血管区(FAZ)面积呈显著相关性(=0.04)。HbA1c>7.5%的DM-DR患者的中心凹视网膜厚度(CRT)大于DM-no DR患者和对照组(分别为270.8、260和251.1μm,<0.05),且HbA1c与CRT呈显著相关性(=0.03)。总之,较高水平的HbA1c与DM-no DR患者的OCTA变化以及DM-DR患者的OCT结构变化相关。OCTA和OCT测量结果与HbA1c水平相结合可能有助于识别有进展至糖尿病微血管疾病更严重阶段风险的患者。